This compound is a pharmaceutical intermediate used as a reference standard for identifying and quantifying impurities in acalabrutinib. It is a research-grade chemical employed in pharmaceutical manufacturing and quality control processes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2230757-49-8
4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide
Acalabrutinib impurity reference standard
(2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester
Acalabrutinib impurity reference standard
1-Methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione
Pharmaceutical impurity reference standard
7-Deschloro-8-chloro Clobazam
Clobazam impurity reference standard
Ethyl 3-((2-amino-5-chlorophenyl)phenylamino)-3-oxopropanoate
impurity of clobazam synthesis
(+)-Solketal
pharmaceutical intermediate for synthesis
4-[8-amino-3-(3,4-dihydro-2H-pyrrol-5-yl)imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
PYLYCDADEDOFBZ-UHFFFAOYSA-N
C1CC(=NC1)C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5